Condition
Inflammatory Joint Diseases
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07748858Recruiting
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
NCT07536529RecruitingPrimary
Oxidative Stress in Autoimmune Rheumatic Diseases
NCT01581294RecruitingPrimary
The Norwegian Antirheumatic Drug Register
Showing all 3 trials